Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1999-12-22
pubmed:abstractText
The presence and possible role of androgen-metabolizing enzymes in androgen-independent prostate carcinoma (CaP) are still unclear. The aim of the present study was: 1) to evaluate the pattern of androgen metabolism (relative production of 5alpha-reduced vs. 17-keto androgens); and 2) to analyze whether one or both the two known 5alpha-reductase isoforms (5alpha-R1 and 5alpha-R2) and the aromatase (Aro) are expressed and active in this pathology.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3-Oxo-5-alpha-Steroid..., http://linkedlifedata.com/resource/pubmed/chemical/Androgens, http://linkedlifedata.com/resource/pubmed/chemical/Androstenedione, http://linkedlifedata.com/resource/pubmed/chemical/Aromatase, http://linkedlifedata.com/resource/pubmed/chemical/Aromatase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Dihydrotestosterone, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Etiocholanolone, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Nitriles, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Testosterone, http://linkedlifedata.com/resource/pubmed/chemical/Triazoles, http://linkedlifedata.com/resource/pubmed/chemical/anastrozole, http://linkedlifedata.com/resource/pubmed/chemical/androstane-3,17-dione
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0270-4137
pubmed:author
pubmed:copyrightInfo
Copyright 1999 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
224-32
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10544295-3-Oxo-5-alpha-Steroid 4-Dehydrogenase, pubmed-meshheading:10544295-Androgens, pubmed-meshheading:10544295-Androstenedione, pubmed-meshheading:10544295-Aromatase, pubmed-meshheading:10544295-Aromatase Inhibitors, pubmed-meshheading:10544295-Blotting, Southern, pubmed-meshheading:10544295-Dihydrotestosterone, pubmed-meshheading:10544295-Enzyme Inhibitors, pubmed-meshheading:10544295-Etiocholanolone, pubmed-meshheading:10544295-Humans, pubmed-meshheading:10544295-Hydrogen-Ion Concentration, pubmed-meshheading:10544295-Isoenzymes, pubmed-meshheading:10544295-Male, pubmed-meshheading:10544295-Microsomes, pubmed-meshheading:10544295-Nitriles, pubmed-meshheading:10544295-Prostatic Hyperplasia, pubmed-meshheading:10544295-Prostatic Neoplasms, pubmed-meshheading:10544295-RNA, Messenger, pubmed-meshheading:10544295-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:10544295-Testosterone, pubmed-meshheading:10544295-Triazoles, pubmed-meshheading:10544295-Tumor Cells, Cultured
pubmed:year
1999
pubmed:articleTitle
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
pubmed:affiliation
Center for Endocrinological Oncology, Department of Endocrinology, University of Milan, Milan, Italy. pnc@mialserver.unimi.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't